25843-45-2
基本信息
氧化偶氮基甲烷
AOM氧化偶氮甲烷
偶氮甲烷(AOM)
结肠癌造模诱导剂氧化偶氮甲烷
PERFEMIKER]氧化偶氮甲烷,95%
AZOXYMETHANE
azoxy-methan
CH3N=N(→O)CH3
Methane, azoxy-
ONN-Azoxydimethane
Dimethyldiazene 1-oxide
Azoxymethane DISCONTINUED
1,2-Dimethyldiazene 1-oxide
(Z)-1,2-diMethyldiazene oxide
物理化学性质
| 沸点 | 97-99 °C(lit.) |
| 密度 | 0.991 g/mL at 25 °C(lit.) |
| 折射率 | 1.4368 (estimate) |
| 闪点 | 24 °C |
| 储存条件 | −20°C |
| 溶解度 | Soluble in water, ethanol, and ether |
| 形态 | Liquid |
| 比重 | 0.991 |
| 颜色 | Oil |
| 主要应用 | genomic analysis |
| InChI | InChI=1S/C2H6N2O/c1-3-4(2)5/h1-2H3 |
| InChIKey | DGAKHGXRMXWHBX-UHFFFAOYSA-N |
| SMILES | [N+]([O-])(C)=NC |
| EPA化学物质信息 | Azoxymethane (25843-45-2) |
安全数据
| 危险性符号(GHS) |    GHS02,GHS06,GHS08 |
| 警示词 | 危险 |
| 危险性描述 | H226-H300-H315-H319-H350 |
| 防范说明 | P201-P202-P210-P301+P310-P303+P361+P353-P305+P351+P338 |
| 危险品标志 | T |
| 危险类别码 | 45-46-10-25-34-36/38 |
| 安全说明 | 53-26-36/37/39-45 |
| 危险品运输编号 | UN 1992 3/PG 3 |
| WGK Germany | 3 |
| RTECS号 | PA2975000 |
| 存储类别 | 3 - Flammable liquids |
| 危险性类别 | Acute Tox. 2 Oral Carc. 1B Eye Irrit. 2 Flam. Liq. 3 Skin Irrit. 2 |
| 毒性 | mma-sat 13,600 mmol/L/20M CNREA8 38,4585,78 |
偶氮甲烷价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2026/09/15 | HY-111375 | 偶氮甲烷 Azoxymethane | 25843-45-2 | 5mg(135mM * 500μL in Water) | 2656元 |
| 2026/09/15 | HY-111375 | 偶氮甲烷 Azoxymethane | 25843-45-2 | 10 mg (135 mM * 1 mL in Water) | 4650元 |
| 2025/05/22 | XW2584345201 | 氧化偶氮甲烷 Azoxymethane | 25843-45-2 | 100mg | 22671元 |
常见问题列表
Azoxymethane is a colon carcinogen which leads to the formation of DNA adducts. On an equal protein basis, hepatic microsomes are much more active than SI and colon microsomes in NADPH-dependent Azoxymethane bioactivation and N 7 -mG adduct formation. Hepatic microsomes show the highest activity in the hydroxylation of Azoxymethane, followed by SI and colon microsomes.
Regardless of the strain, the amounts of O 6 -mG and N 7 -mG produced by Azoxymethane are highest in the liver, followed by proximal and distal colons, which have similar levels, and then by duodenum, jejunum and ileum. Results indicate that the Azoxymethane-induced DNA adduct formation in the SI and colon does not depend on bioactivation by hepatic P450 enzymes. Irrespective of the mouse strain, no aberrant crypt foci (ACF) is detected in the colons of saline-treated mice; in contrast, colonic ACF is detected in all three strains of Azoxymethane-treated mice. The Azoxymethane-treated athymic mice have approximately an 11-fold lower tumor incidence than similarly treated WT animals.